Skip to content

tDCS to Treat Hemiplegic Shoulder Pain

Assesing Hemiplegic Shoulder Pain and the Use of tDCS to Treat This Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02929784
Enrollment
100
Registered
2016-10-11
Start date
2018-11-01
Completion date
2020-11-01
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Hemiplegic Shoulder Pain, transcranial Direct Current Stimulation, Stroke

Brief summary

The purpose of the study is to investigate the possibility of treating Hemiplegic Shoulder Pain (HSP) using transcranial direct current stimulation (tDCS) in patients following stroke. The secondary aims are to see if this treatment affects motor function of the upper limb, to asses the different types of HSP and whether there is any correlation to the location and extent of the stroke.

Detailed description

Hemiplegic Shoulder Pain (HSP) is a common entity following stroke. It's prevalence varies between studies, probably because it includes many etiologies and there is no one way of diagnosis. HSP delays rehabilitation, elongates hospitalization time and reduces quality of life. Currently there is no one reccomended treatment for HSP. Weak transcranial direct current stimulation (tDCS) induces persisting excitability changes in the human motor cortex. this effect depends on the stimulation polarity and is specific to the site of stimulation. Interacting with cortical activity, by means of cortical stimulation, can improve the rehabilitation potential of neurologic patients. In this respect, preliminary evidence suggests that cortical stimulation may play a role in treating aphasia, unilateral neglect, and chronic pain disorders. In this tDCS study the investigator uses one anode and one cathode electrode placed over the scalp to modulate a particular area of the central nervous system (CNS). The stimulation is administered via the neuroConn DC.Stimulator. The DC-STIMULATOR is a micro-processor-controlled constant current source. The DCSTIMULATOR is a CE-certified medical device for conducting non-invasive transcranial direct current stimulation (tDCS) on people.Electrode positioning is determined according to the International EEG 10-20 System.

Interventions

DEVICEIntervention

Device: neuroConn\_CE\_DC-STIMULATOR. Anodal stimulation to affected hemisphere.

DEVICESham

no meaningful stimulation will be given.

Sponsors

Loewenstein Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients hospitalized in the department of neurologic rehabilitation of Loewenstein Rehabilitation Center after first clinical stroke. * Able to understand and comply with basic instructions * Signed an informed consent form * Hebrew speaking

Exclusion criteria

* Shoulder pain predating the stroke * Epilepsy

Design outcomes

Primary

MeasureTime frameDescription
Change in VAS (Visual Ananlof Scale) for pain assessment1 monthusing an validated score 0 (lowest) to 10 (highest)

Secondary

MeasureTime frameDescription
Change in Fugl-Meyer assessment1 monthThe Fugl-Meyer Assessment is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia.Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score is 226.

Contacts

Primary ContactOsnat Granot
osnatel@clalit.org.il97297709957

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026